Valsartan MDL Judge Refuses to Lift Sanctions Against Defendant ZHP
August 26, 2024
DOCUMENTS
- Order
CAMDEN, N.J. — The judge overseeing the Valsartan drugs MDL docket has denied defendant Zhejiang Huahai Pharmaceutical Company Ltd. (ZHP)’s motion to reverse a special master’s order imposing sanctions on the company for its refusal to produce its CEO for a deposition.
In a one-page order, Judge Renee M. Bumb of the U.S. District Court for the District of New Jersey rejected ZHP’s argument that it made good faith attempts to comply with discovery orders and that the sanctions proposed by Hon. Thomas I. Vanaskie (Ret.) are “excessive and unjust.”
The lawsuits accuse ZHP and other drug manufacturers of selling …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach